Work Here?
Work Here?
Work Here?
Tango Therapeutics develops targeted cancer treatments using the principle of synthetic lethality, which allows them to design drugs that kill cancer cells while leaving healthy cells unharmed. Their approach focuses on the interaction between genes, where the loss of both genes leads to cell death, but the loss of just one does not. This method enables them to create more effective therapies for cancer patients. Tango operates in the oncology market, primarily serving healthcare providers and pharmaceutical companies. They collaborate with larger firms, like Gilead Sciences, to co-develop therapies, which helps them secure funding and speed up the development process. Their goal is to bring next-generation targeted immunotherapies to market, supported by a strong team and strategic partnerships.
Company Stage
IPO
Employees
51-200
Industries
Biotechnology, Healthcare
Total Funding
$341.4M
Headquarters
Cambridge, Massachusetts
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Hybrid Work Options
Find jobs on Simplify and start your career today